Department of Biotechnology and Molecular Medicine, A.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, Finland.
Int J Mol Med. 2013 Aug;32(2):410-22. doi: 10.3892/ijmm.2013.1395. Epub 2013 May 28.
Sindbis vectors have shown remarkable antitumor efficacy and tumor-targeting capacity in animal models and hold promise for cancer therapy. Different packaging systems are used to produce propagation-incompetent Sindbis vectors. However, the vectors produced using either DH-BB single helper RNA or split helper RNA can spread in permissive cell cultures. We investigated the mechanisms of vector spreading and show, here, that recombination occurs between the replicon and DH-BB helper RNA, leading to formation of the full-length virus genome. Split helper RNA may not completely prevent wild-type reversion, although the frequency is greatly reduced. Contrary to propagation of Sindbis DH-BB vectors, Sindbis split helper vectors were frequently able to spread without cytopathic effect (CPE), a feature that was linked to wild-type reversion. Our results support the hypothesis that the non-cytopathic local spreading constantly observed with Sindbis split helper vector results from unspecific packaging of helper RNAs into vector particles and co-infection with particles containing replicon and helper RNAs. Several malignant cell lines with defective interferon responses were found to be permissive for non-cytopathic spreading of the Sindbis split helper vector. Interferon-α suppressed the spreading providing a possible option to control the vector.
辛德比斯载体在动物模型中表现出显著的抗肿瘤疗效和肿瘤靶向能力,有望用于癌症治疗。不同的包装系统被用于生产无增殖能力的辛德比斯载体。然而,使用 DH-BB 单辅助 RNA 或分割辅助 RNA 生产的载体可以在允许的细胞培养物中传播。我们研究了载体传播的机制,并在此表明,复制子和 DH-BB 辅助 RNA 之间发生了重组,导致全长病毒基因组的形成。虽然频率大大降低,但分割辅助 RNA 可能不完全阻止野生型回复。与辛德比斯 DH-BB 载体的传播相反,辛德比斯分割辅助载体经常能够在没有细胞病变效应(CPE)的情况下传播,这一特征与野生型回复有关。我们的结果支持这样一种假设,即辛德比斯分割辅助载体经常观察到的非致病变局部传播是由于辅助 RNA 非特异性包装到载体颗粒中,并与含有复制子和辅助 RNA 的颗粒共同感染。发现几种干扰素反应缺陷的恶性细胞系对辛德比斯分割辅助载体的非致病变传播具有易感性。干扰素-α抑制了载体的传播,为控制载体提供了一种可能的选择。